Profile
Andrew L.
Ross is currently the Director at RallyPoint Networks, Inc. He previously served as the Chairman at iSpecimen, Inc. from 2012 to 2024.
He also held the position of Director at Q-State Biosciences, Inc. and Q-State Holdings, Inc. from 2013 to 2020.
Andrew Ross active positions
| Companies | Position | Start |
|---|---|---|
RallyPoint Networks, Inc.
RallyPoint Networks, Inc. Commercial Printing/FormsCommercial Services Provides online network for current and former Military members | Director/Board Member | - |
Former positions of Andrew Ross
| Companies | Position | End |
|---|---|---|
| ISPECIMEN INC. | Chairman | 25/07/2024 |
Q-State Holdings, Inc.
Q-State Holdings, Inc. BiotechnologyHealth Technology Functions as an holding company whose subsidiaries provides biotechnology services | Director/Board Member | 01/02/2020 |
Q-State Biosciences, Inc.
Q-State Biosciences, Inc. BiotechnologyHealth Technology Develops optical electrophysiology platform for controlling and recording activity in electrically active cells | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
iSpecimen, Inc.
iSpecimen, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in procurement of human biospecimens | Commercial Services |
RallyPoint Networks, Inc.
RallyPoint Networks, Inc. Commercial Printing/FormsCommercial Services Provides online network for current and former Military members | Commercial Services |
Q-State Biosciences, Inc.
Q-State Biosciences, Inc. BiotechnologyHealth Technology Develops optical electrophysiology platform for controlling and recording activity in electrically active cells | Health Technology |
Q-State Holdings, Inc.
Q-State Holdings, Inc. BiotechnologyHealth Technology Functions as an holding company whose subsidiaries provides biotechnology services | Health Technology |
- Stock Market
- Insiders
- Andrew Ross
















